Evommune EVMN
NYSE EVMN
$5.18 -0.20 (-3.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

Evommune (EVMN) Market Capitalization (2025 - 2026)

Updated

Evommune (EVMN) posted Market Capitalization of $482.18 million for Q2 2026, down 41.8% from the prior quarter.

Analysis

Evommune (EVMN) Market Capitalization (2025 - 2026) Analysis & Trends

For FY2025, Evommune's Market Capitalization came in at $105.06 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Evommune 186.46 Mn -451.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 482.18 Mn
Mar 31, 2026 828.06 Mn
Dec 31, 2025 105.06 Mn
API Access

Evommune Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=EVMN&period=max&api_key=YOUR_API_KEY